vs
EMPIRE PETROLEUM CORP（EP）与瓦里安医疗系统（UTMD）财务数据对比。点击上方公司名可切换其他公司
瓦里安医疗系统的季度营收约是EMPIRE PETROLEUM CORP的1.3倍（$9.0M vs $7.1M），瓦里安医疗系统净利率更高（28.4% vs -835.1%，领先863.5%），瓦里安医疗系统同比增速更快（-1.2% vs -30.0%），过去两年瓦里安医疗系统的营收复合增速更高（-10.7% vs -13.3%）
伊拉克石油公司，前身为土耳其石油公司，是一家石油企业，1925年至1961年间几乎垄断了伊拉克境内所有石油勘探与开采业务，由当时全球多家顶尖石油企业共同持股，公司总部设立于英国伦敦。
瓦里安医疗系统是一家总部位于美国加利福尼亚州帕洛阿尔托的肿瘤放射治疗设备与软件制造商，其产品包括直线加速器以及用于放射治疗、放射外科、质子治疗、短距离放射治疗等癌症及其他病症治疗的相关软件，同时为癌症诊疗中心、放射治疗中心提供运营管理软件，全球员工规模超过7100人。
EP vs UTMD — 直观对比
营收规模更大
UTMD
是对方的1.3倍
$7.1M
营收增速更快
UTMD
高出28.8%
-30.0%
净利率更高
UTMD
高出863.5%
-835.1%
两年增速更快
UTMD
近两年复合增速
-13.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.1M | $9.0M |
| 净利润 | $-59.0M | $2.6M |
| 毛利率 | — | 58.2% |
| 营业利润率 | -834.5% | 27.0% |
| 净利率 | -835.1% | 28.4% |
| 营收同比 | -30.0% | -1.2% |
| 净利润同比 | -1306.0% | -11.6% |
| 每股收益（稀释后） | $-1.74 | $0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPUTMD
| Q4 25 | $7.1M | $9.0M | ||
| Q3 25 | $9.4M | $9.8M | ||
| Q2 25 | $8.8M | $10.0M | ||
| Q1 25 | $9.0M | $9.7M | ||
| Q4 24 | $10.1M | $9.2M | ||
| Q3 24 | $11.4M | $10.0M | ||
| Q2 24 | $12.8M | $10.4M | ||
| Q1 24 | $9.4M | $11.3M |
净利润EPUTMD
| Q4 25 | $-59.0M | $2.6M | ||
| Q3 25 | $-3.8M | $2.6M | ||
| Q2 25 | $-5.1M | $3.0M | ||
| Q1 25 | $-4.2M | $3.0M | ||
| Q4 24 | $-4.2M | $2.9M | ||
| Q3 24 | $-3.6M | $3.6M | ||
| Q2 24 | $-4.4M | $3.5M | ||
| Q1 24 | $-4.0M | $4.0M |
毛利率EPUTMD
| Q4 25 | — | 58.2% | ||
| Q3 25 | — | 57.1% | ||
| Q2 25 | — | 56.2% | ||
| Q1 25 | — | 57.0% | ||
| Q4 24 | — | 58.1% | ||
| Q3 24 | — | 58.0% | ||
| Q2 24 | — | 60.1% | ||
| Q1 24 | — | 59.7% |
营业利润率EPUTMD
| Q4 25 | -834.5% | 27.0% | ||
| Q3 25 | -37.8% | 26.6% | ||
| Q2 25 | -56.0% | 32.1% | ||
| Q1 25 | -43.9% | 32.5% | ||
| Q4 24 | -38.9% | 32.0% | ||
| Q3 24 | -30.0% | 33.4% | ||
| Q2 24 | -15.0% | 33.1% | ||
| Q1 24 | -46.8% | 34.2% |
净利率EPUTMD
| Q4 25 | -835.1% | 28.4% | ||
| Q3 25 | -40.9% | 26.8% | ||
| Q2 25 | -57.8% | 30.6% | ||
| Q1 25 | -46.9% | 31.3% | ||
| Q4 24 | -41.6% | 31.7% | ||
| Q3 24 | -32.0% | 35.6% | ||
| Q2 24 | -34.3% | 33.2% | ||
| Q1 24 | -42.3% | 34.9% |
每股收益（稀释后）EPUTMD
| Q4 25 | $-1.74 | $0.80 | ||
| Q3 25 | $-0.11 | $0.82 | ||
| Q2 25 | $-0.15 | $0.94 | ||
| Q1 25 | $-0.12 | $0.92 | ||
| Q4 24 | $-0.12 | $0.86 | ||
| Q3 24 | $-0.12 | $1.03 | ||
| Q2 24 | $-0.15 | $0.98 | ||
| Q1 24 | $-0.15 | $1.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $85.8M |
| 总债务越低越好 | — | $225.0K |
| 股东权益账面价值 | $-4.6M | $119.3M |
| 总资产 | $65.9M | $122.5M |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资EPUTMD
| Q4 25 | $1.2M | $85.8M | ||
| Q3 25 | $4.6M | $84.3M | ||
| Q2 25 | $2.3M | $82.2M | ||
| Q1 25 | $1.1M | $83.3M | ||
| Q4 24 | $2.3M | $83.0M | ||
| Q3 24 | $3.1M | $88.5M | ||
| Q2 24 | $9.3M | $89.2M | ||
| Q1 24 | $3.5M | $93.8M |
总债务EPUTMD
| Q4 25 | — | $225.0K | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $14.6M | — | ||
| Q1 25 | $11.6M | $269.0K | ||
| Q4 24 | $11.3M | $282.0K | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.5M | — |
股东权益EPUTMD
| Q4 25 | $-4.6M | $119.3M | ||
| Q3 25 | $53.7M | $118.3M | ||
| Q2 25 | $54.5M | $117.5M | ||
| Q1 25 | $59.1M | $117.0M | ||
| Q4 24 | $62.8M | $117.4M | ||
| Q3 24 | $56.5M | $124.2M | ||
| Q2 24 | $58.7M | $124.1M | ||
| Q1 24 | $31.7M | $127.7M |
总资产EPUTMD
| Q4 25 | $65.9M | $122.5M | ||
| Q3 25 | $123.0M | $122.0M | ||
| Q2 25 | $124.7M | $120.8M | ||
| Q1 25 | $123.7M | $122.5M | ||
| Q4 24 | $123.9M | $122.5M | ||
| Q3 24 | $121.2M | $129.7M | ||
| Q2 24 | $119.9M | $130.0M | ||
| Q1 24 | $100.1M | $135.4M |
负债/权益比EPUTMD
| Q4 25 | — | 0.00× | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.20× | 0.00× | ||
| Q4 24 | 0.18× | 0.00× | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $3.5M |
| 自由现金流经营现金流 - 资本支出 | — | $3.4M |
| 自由现金流率自由现金流/营收 | — | 37.2% |
| 资本支出强度资本支出/营收 | — | 1.2% |
| 现金转化率经营现金流/净利润 | — | 1.36× |
| 过去12个月自由现金流最近4个季度 | — | $14.3M |
8季度趋势，按日历期对齐
经营现金流EPUTMD
| Q4 25 | $-2.8M | $3.5M | ||
| Q3 25 | $330.0K | $3.9M | ||
| Q2 25 | $-3.1M | $2.9M | ||
| Q1 25 | $1.6M | $4.5M | ||
| Q4 24 | $-8.8M | $2.9M | ||
| Q3 24 | $12.8M | $3.9M | ||
| Q2 24 | $-1.8M | $2.8M | ||
| Q1 24 | $3.9M | $5.3M |
自由现金流EPUTMD
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | $3.9M | ||
| Q2 25 | — | $2.8M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $3.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $5.3M |
自由现金流率EPUTMD
| Q4 25 | — | 37.2% | ||
| Q3 25 | — | 39.2% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 44.1% | ||
| Q4 24 | — | 32.0% | ||
| Q3 24 | — | 37.7% | ||
| Q2 24 | — | 25.5% | ||
| Q1 24 | — | 46.3% |
资本支出强度EPUTMD
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.2% |
现金转化率EPUTMD
| Q4 25 | — | 1.36× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 1.47× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.08× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 1.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
